Evonik Industries Buys Tessenderlo's Glycine Business

Evonik Industries says it has acquired the customer list for the pharmaceutical amino acid glycine from Tessenderlo Group (Brussels). Tessenderlo, which is currently undergoing a major portflio shuffle, announced last year that it would exit the glycine market by end of 2010 and will close the Tessenderlo based plant, because of "structural problems in the European market and competition from China." Evonik also has the option to acquire Tessenderlo's specialized glycine production equipment. Evonik makes the amino acid under strict cGMP specifications...

This information is only available to Chemical Week subscribers.

Forgot your user ID or password?
Click here to have it sent to you.

Email Address First Name Last Name

Not an IHS Chemical Week 24/7 member yet? Here's why you should be: Searchable online archive access of the last 2 years of Chemical Week. Print or digital magazine subscription Price and market change alerts Economic data and statistics Buyers' Guides Webcasts | whitepapers